ALEUP.PA Europlasma (EURONEXT) up 34.82% intraday 19 Mar 2026: high volume points to speculative rally

ALEUP.PA stock climbed 34.82% intraday to €0.0333 on EURONEXT on 19 Mar 2026, driven by heavy trading and a low market cap that magnifies moves. We see a spike in volume at 5,238,308 shares and a relative volume of 4.81, which suggests short-term speculation rather than broad fundamental change. Europlasma S.A. (ALEUP.PA) remains small with a market cap near €89,202, negative EPS of -88.61, and volatile technicals. Below we break down drivers, valuation, Meyka AI grade and short-term forecast to frame risk and opportunity for traders watching top gainers this intraday session.

Intraday price action on ALEUP.PA stock

The intraday range moved from a low of €0.0303 to a high of €0.0365, after opening at €0.0330 and closing higher than the previous close of €0.0247. The reported one-day change is +€0.0086 or +34.82%, driven by a volume surge to 5,238,308 shares compared with an average volume of 3,889,737. Thin market cap and a small free float make large percentage moves common on EURONEXT for ALEUP.PA.

What moved the tape: news and market context for ALEUP.PA stock

There is no single company press release in the last 48 hours; market attention appears to come from listed quotes and coverage on platforms like Investing. Short bursts of buy interest often follow retail and platform listings. Sector context matters: Industrials and Waste Management peers trade with higher average metrics, so Europlasma’s micro-cap status and recent trading indicate event-driven momentum rather than sector-led strength. See coverage on Investing (DE) and Investing (FR).

Valuation and financials for ALEUP.PA stock

Europlasma shows extreme distortions: market cap €89,202, EPS -88.61, and price averages at 50-day €0.0698 and 200-day €4.0849. Key ratios reveal negative earnings, negative book value per share (-74.92) and enterprise value €6,909,202.00, indicating capital structure quirks and very low liquidity. These figures make traditional valuation comparisons unreliable; investors should treat listed metrics as red flags, not buy signals.

Technical read and liquidity signals for ALEUP.PA stock

Momentum indicators show RSI 38.84 and ADX 26.30, suggesting a trend with limited participation. Bollinger Bands sit at 0.02–0.04, while on‑balance volume is deeply negative, but the intraday volume spike pushed price higher. Relative volume 4.81 confirms abnormal trading. With a tiny free float, volume surges will keep volatility high and execution risk significant for larger orders.

Meyka AI rates ALEUP.PA with a score out of 100

Meyka AI rates ALEUP.PA with a score out of 100: 66.37 / 100 — Grade B — Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Note the external company rating of C (Sell) dated 2026-03-18; our grade emphasizes short-term model signals and liquidity, not a bullish endorsement. Meyka AI is an AI-powered market analysis platform and this is informational, not investment advice.

Forecasts, price targets and risk profile for ALEUP.PA stock

Meyka AI’s forecast model projects a monthly target €0.11 and a quarterly figure €0.37. Versus the current price €0.0333, that implies a model-based upside of +230.36% to the monthly figure and +1,010.81% to the quarterly figure. Forecasts are model-based projections and not guarantees. Given tiny market cap, negative fundamentals and wide dispersion in analyst signals, realistic trader scenarios should include a conservative short-term target near €0.07 and an aggressive scenario near €0.37, with high probability of reversal.

Final Thoughts

ALEUP.PA stock is trading as a top intraday gainer on EURONEXT largely because of very low market cap, a surge in volume to 5,238,308 shares and a relative volume of 4.81, not because of clear fundamental recovery. Short-term traders can find momentum opportunities, but the company shows negative EPS -88.61, negative book value and an enterprise value mismatch that raise solvency and valuation concerns. Meyka AI’s forecast model projects monthly €0.11 and quarterly €0.37, implying model-based upside of +230.36% and +1,010.81% respectively versus the current price €0.0333; these projections carry large model and liquidity risk. We recommend strict position sizing, clear stop-loss rules and monitoring of trading publications and official company updates. For a quick reference see the Europlasma page on Meyka: Europlasma (ALEUP.PA) on Meyka. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.